WHO reviewing COVID-19 vaccines from China, AstraZeneca for emergency listing

WHO reviewing COVID-19 vaccines from China, AstraZeneca for emergency listing

WHO reviewing COVID-19 vaccines from China, AstraZeneca for emergency listing Urging vaccine developers to submit data on promising candidates    ZURICH- The World Health Organization is reviewing COVID-19 vaccines from AstraZeneca and Chinese developers for possible emergency listing, its top immunization and vaccination expert said on Thursday, following the United Nation's health agency's listing of a vaccine from Pfizer and BioNTech on Dec. 31."We are under review of some of the vaccines from China, for the AstraZeneca vaccine. We are in discussions and beginning processes with other vaccines," WHO immunization director Kate O'Brien told an online social media event, urging vaccine developers to submit data on promising candidates.(Reporting by John Miller, Editing by Michael Shields) (([email protected]; +41 41 528 3630; Reuters Messaging: [email protected]))Zawya CoverageconstructionSaudi contractor Al Khodari appoints new CEOreal estateOver 1,000 Dubai flats, villas sold for $4.5mln in one weekeconomyLebanese business conditions saw minor upturn in DecemberequitiesQ4 forecasts: Saudi's SABIC to post $427mln net profit, Al Rajhi earnings to surgereal estateDubai home prices nearly stable, overall market still in declineMoreReuters Coverageoil and gasBP relaunches sale of North Sea oilfields -sourceshealthcareCOVID-19 vaccine deliveries under COVAX could start this month - WHOsecuritySome Trump supporters expected in court, as police hunt for